Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA GUIDANCE ON TREND ANALYSIS OF ADVERSE EVENTS UNDER MDR

This article was originally published in The Gray Sheet

Executive Summary

FDA GUIDANCE ON TREND ANALYSIS OF ADVERSE EVENTS UNDER MDR is due out by the end of the year, Janet Arrowsmith-Lowe, acting director of the device center's Office of Surveillance and Biometrics, said during a Sept. 27 teleconference on upcoming changes to the agency's medical device reporting (MDR) regulations. The agency currently is "working with industry to develop standardized methods of trend analysis," with the expectation of having a guidance document on "how to apply methodologies" available to manufacturers by the end of the year, Arrowsmith-Lowe said. Industry groups providing input to the agency include the Health Industry Manufacturers Association and the National Electrical Manufacturers Association.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT002880

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel